AleksandrLombrozo

Cleveland BioLabs is at the bottom of the weekly box

Long
NASDAQ:CBLI   None
Despite reporting $1.9 million net loss for the second quarter of 2016 technical analysis stipulates the shares of the company would at least double its value.
The point is that there was a bullish engulfing at the bottom of a significant rectangle which lasts more than a year. Moreover RSI(5) analysis implies divergence which coupled with double bottom increases the chances a winning trade.
For more ideas visit mercurius.wordpress.com

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.